Alexandra J. Greenberg, Ph.D. - Publications

Affiliations: 
2014 Clinical and Translational Science College of Medicine - Mayo Clinic 
Area:
Epidemiology, Oncology

27 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2018 Clay-Gilmour AI, Kumar S, Rajkumar SV, Rishi A, Kyle RA, Katzmann JA, Murray DL, Norman AD, Greenberg AJ, Larson DR, O'Byrne MM, Slager SL, Vachon CM. Risk of MGUS in relatives of multiple myeloma cases by clinical and tumor characteristics. Leukemia. PMID 30201985 DOI: 10.1038/S41375-018-0246-2  0.487
2017 Greenberg AJ, Falisi AL, Finney Rutten LJ, Chou WS, Patel V, Moser RP, Hesse BW. Access to Electronic Personal Health Records Among Patients With Multiple Chronic Conditions: A Secondary Data Analysis. Journal of Medical Internet Research. 19: e188. PMID 28576755 DOI: 10.2196/Jmir.7417  0.318
2017 Taparra K, Pepin K, Moser R, Hesse B, Greenberg A. Abstract 4222: Examining sociodemographic disparities in perceptions of cancer risk from medical imaging radiation Cancer Research. 77: 4222-4222. DOI: 10.1158/1538-7445.Am2017-4222  0.326
2016 Hesse BW, Greenberg AJ, Rutten LJ. The role of Internet resources in clinical oncology: promises and challenges. Nature Reviews. Clinical Oncology. PMID 27273045 DOI: 10.1038/Nrclinonc.2016.78  0.316
2016 Clay AI, Rishi A, Kumar S, Rajkumar SV, Greenberg AJ, Larson DR, O'Byrne MM, Slager SL, Vachon CM. Risk of Monoclonal Gammopathy of Undetermined Significance in First-Degree Relatives of Multiple Myeloma Cases By Cytogenetic Subtype Blood. 128: 4425-4425. DOI: 10.1182/Blood.V128.22.4425.4425  0.534
2015 Ziv E, Dean E, Hu D, Martino A, Serie D, Curtin K, Campa D, Aftab B, Bracci P, Buda G, Zhao Y, Caswell-Jin J, Diasio R, Dumontet C, Dudziński M, ... ... Greenberg A, et al. Corrigendum: Genome-wide association study identifies variants at 16p13 associated with survival in multiple myeloma patients. Nature Communications. 6: 10203. PMID 26648255 DOI: 10.1038/Ncomms10203  0.316
2015 Ziv E, Dean E, Hu D, Martino A, Serie D, Curtin K, Campa D, Aftab B, Bracci P, Buda G, Zhao Y, Caswell-Jin J, Diasio R, Dumontet C, Dudzi?ski M, ... ... Greenberg A, et al. Genome-wide association study identifies variants at 16p13 associated with survival in multiple myeloma patients. Nature Communications. 6: 7539. PMID 26198393 DOI: 10.1038/Ncomms8539  0.375
2015 Chawla SS, Kumar SK, Dispenzieri A, Greenberg AJ, Larson DR, Kyle RA, Lacy MQ, Gertz MA, Rajkumar SV. Clinical Course and Prognosis of Non-Secretory Multiple Myeloma. European Journal of Haematology. PMID 25690913 DOI: 10.1111/ejh.12534  0.376
2015 Greenberg AJ, Philip S, Paner A, Velinova S, Badros A, Catchatourian R, Ketterling R, Kyle RA, Kumar S, Vachon CM, Rajkumar SV. Racial differences in primary cytogenetic abnormalities in multiple myeloma: a multi-center study. Blood Cancer Journal. 5: e279. PMID 25679291 DOI: 10.1038/Bcj.2015.8  0.435
2015 Greenberg AJ, Philip S, Paner A, Velinova S, Badros A, Catchatourian R, Ketterling R, Kyle RA, Kumar S, Vachon CM, Rajkumar SV. Racial differences in primary cytogenetic abnormalities in multiple myeloma: a multi-center study. Blood Cancer Journal. 5: e271. PMID 25555162 DOI: 10.1038/Bcj.2014.91  0.498
2015 Chawla SS, Kumar SK, Dispenzieri A, Greenberg AJ, Larson DR, Kyle RA, Lacy MQ, Gertz MA, Rajkumar SV. Clinical course and prognosis of non-secretory multiple myeloma. European Journal of Haematology. 95: 57-64. PMID 25382589 DOI: 10.1111/Ejh.12478  0.446
2014 Landgren O, Graubard BI, Katzmann JA, Kyle RA, Ahmadizadeh I, Clark R, Kumar SK, Dispenzieri A, Greenberg AJ, Therneau TM, Melton LJ, Caporaso N, Korde N, Roschewski M, Costello R, et al. Racial disparities in the prevalence of monoclonal gammopathies: a population-based study of 12,482 persons from the National Health and Nutritional Examination Survey. Leukemia. 28: 1537-42. PMID 24441287 DOI: 10.1038/Leu.2014.34  0.501
2014 Greenberg AJ, Rajkumar SV, Therneau TM, Singh PP, Dispenzieri A, Kumar SK. Relationship between initial clinical presentation and the molecular cytogenetic classification of myeloma. Leukemia. 28: 398-403. PMID 24005246 DOI: 10.1038/leu.2013.258  0.379
2014 Ziv E, Dean E, Hu D, Martino A, Serie D, Campa D, Aftab B, Bracci P, Buda G, Caswell J, Dumontet C, Dudziński M, Fejerman L, Greenberg A, Hunstman S, et al. Abstract 5078: Genome wide association study identifies variants at 16p13 associated with survival in multiple myeloma patients Cancer Research. 74: 5078-5078. DOI: 10.1158/1538-7445.Am2014-5078  0.351
2014 Greenberg AJ, Philip S, Paner A, Velinova S, Badros A, Catchatorian R, Larson D, Ketterling R, Kyle RA, Kumar S, Vachon CM, Rajkumar SV. Abstract 272: Evidence of decreased prevalence of the t(11;14) translocation in black patients with multiple myeloma: A multi-center study Cancer Research. 74: 272-272. DOI: 10.1158/1538-7445.Am2014-272  0.513
2013 Greenberg AJ, Walters DK, Kumar SK, Vincent Rajkumar S, Jelinek DF. Responsiveness of cytogenetically discrete human myeloma cell lines to lenalidomide: lack of correlation with cereblon and interferon regulatory factor 4 expression levels. European Journal of Haematology. 91: 504-13. PMID 23992230 DOI: 10.1111/Ejh.12192  0.326
2013 Greenberg AJ, Cousin M, Kumar S, Ketterling RP, Knudson RA, Larson D, Colby C, Scott C, Vachon CM, Rajkumar SV. Differences in the distribution of cytogenetic subtypes between multiple myeloma patients with and without a family history of monoclonal gammopathy and multiple myeloma. European Journal of Haematology. 91: 193-5. PMID 23647020 DOI: 10.1111/Ejh.12133  0.484
2013 Greenberg AJ, Lee AM, Serie DJ, McDonnell SK, Cerhan JR, Liebow M, Larson DR, Colby CL, Norman AD, Kyle RA, Kumar S, Rajkumar SV, Diasio RB, Slager SL, Vachon CM. Single-nucleotide polymorphism rs1052501 associated with monoclonal gammopathy of undetermined significance and multiple myeloma. Leukemia. 27: 515-6. PMID 22945773 DOI: 10.1038/Leu.2012.232  0.415
2013 Greenberg AJ, Walters DK, Arendt BK, Tschumper RC, Kumar SK, Rajkumar SV, Jelinek DF. Responsiveness Of Cytogenetically Discrete Human Myeloma Cell Lines To Lenalidomide: Lack Of Correlation With Cereblon and Interferon Regulatory Factor 4 Expression Levels Blood. 122: 1962-1962. DOI: 10.1182/Blood.V122.21.1962.1962  0.431
2012 Greenberg AJ, Rajkumar SV, Larson DR, Dispenzieri A, Therneau TM, Colby CL, Phelps TK, Kumar SK, Katzmann JA, Kyle RA, Slager SL, Vachon CM. Increased prevalence of light chain monoclonal gammopathy of undetermined significance (LC-MGUS) in first-degree relatives of individuals with multiple myeloma. British Journal of Haematology. 157: 472-5. PMID 22629552 DOI: 10.1111/J.1365-2141.2012.09075.X  0.464
2012 Greenberg AJ, Rajkumar SV. Elucidating disparities across racial and ethnic groups in multiple myeloma patients. International Journal of Hematology. 95: 453-4. PMID 22403056 DOI: 10.1007/S12185-012-1040-Y  0.526
2012 Greenberg AJ, Rajkumar SV, Vachon CM. Familial monoclonal gammopathy of undetermined significance and multiple myeloma: epidemiology, risk factors, and biological characteristics. Blood. 119: 5359-66. PMID 22354002 DOI: 10.1182/Blood-2011-11-387324  0.487
2012 Kumar S, Fonseca R, Ketterling RP, Dispenzieri A, Lacy MQ, Gertz MA, Hayman SR, Buadi FK, Dingli D, Knudson RA, Greenberg A, Russell SJ, Zeldenrust SR, Lust JA, Kyle RA, et al. Trisomies in multiple myeloma: impact on survival in patients with high-risk cytogenetics. Blood. 119: 2100-5. PMID 22234687 DOI: 10.1182/Blood-2011-11-390658  0.501
2012 Greenberg AJ, Vachon CM, Rajkumar SV. Disparities in the prevalence, pathogenesis and progression of monoclonal gammopathy of undetermined significance and multiple myeloma between blacks and whites. Leukemia. 26: 609-14. PMID 22193966 DOI: 10.1038/Leu.2011.368  0.491
2012 Greenberg A, Cousin M, Vachon CM, Larson D, Colby CL, Kumar SK, Rajkumar SV. Differences in the Distribution of Cytogenetic Subtypes Between Multiple Myeloma Patients with and without a History of Familial MGUS and Multiple Myeloma Blood. 120: 4000-4000. DOI: 10.1182/Blood.V120.21.4000.4000  0.502
2012 Greenberg AJ, Rajkumar SV, Larson DR, Dispenzieri A, Therneau TM, Colby CL, Phelps TK, Kumar SK, Katzmann JA, Kyle RA, Slager SL, Vachon CM. Abstract 5485: Increased prevalence of light chain monoclonal gammopathy of undetermined significance (MGUS) in first-degree relatives of individuals with multiple myeloma or MGUS Cancer Research. 72: 5485-5485. DOI: 10.1158/1538-7445.Am2012-5485  0.501
2011 Velinova S, Catchatourian R, Kumar S, Rajkumar SV, Greenberg A, Singla S. Racial Disparities in Cytogenetic Characteristics and Outcome of Multiple Myeloma Blood. 118: 1808-1808. DOI: 10.1182/Blood.V118.21.1808.1808  0.517
Show low-probability matches.